Direct-acting antiviral (NS5A inhibitor)
Daclatasvir
- Brands
- 1
- Forms
- Tablet 60 mg
- Used in
- 1 protocols
- Status
- Not verified
Brand list not yet checked by a pharmacist. Confirm in the DRAP registered-drugs database.
Indications
- Used for
- Chronic hepatitis C, combined with sofosbuvir.
Cautions
- Dose adjustment with strong CYP3A inducers/inhibitors
Brands in Pakistan
DaklinzaBristol-Myers Squibb